134 related articles for article (PubMed ID: 1361577)
21. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats.
Barks JD; Liu XH; Sun R; Silverstein FS
Neuroscience; 1997 Jan; 76(2):397-409. PubMed ID: 9015325
[TBL] [Abstract][Full Text] [Related]
22. Concurrent activation of hippocampal glycine and polyamine sites of the N-methyl-D-aspartate receptor synergistically reverses working memory deficits in rats.
Kishi A; Ohno M; Watanabe S
Neurosci Lett; 1998 Dec; 257(3):131-4. PubMed ID: 9870337
[TBL] [Abstract][Full Text] [Related]
23. Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum.
Khakpai F; Nasehi M; Haeri-Rohani A; Eidi A; Zarrindast MR
Behav Brain Res; 2012 May; 231(1):1-10. PubMed ID: 22421366
[TBL] [Abstract][Full Text] [Related]
24. Noradrenergic DSP-4 lesions aggravate impairment of working memory produced by hippocampal muscarinic blockade in rats.
Ohno M; Yoshimatsu A; Kobayashi M; Watanabe S
Pharmacol Biochem Behav; 1997; 57(1-2):257-61. PubMed ID: 9164580
[TBL] [Abstract][Full Text] [Related]
25. Intrahippocampal administration of (+)-SKF 10,047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats.
Ohno M; Watanabe S
Brain Res; 1995 Jul; 684(2):237-42. PubMed ID: 7583231
[TBL] [Abstract][Full Text] [Related]
26. Enhanced N-methyl-D-aspartate function reverses working memory failure induced by blockade of group I metabotropic glutamate receptors in the rat hippocampus.
Ohno M; Watanabe S
Neurosci Lett; 1998 Jan; 240(1):37-40. PubMed ID: 9488169
[TBL] [Abstract][Full Text] [Related]
27. Impairment of working memory induced by scopolamine in rats with noradrenergic DSP-4 lesions.
Ohno M; Yamamoto T; Kobayashi M; Watanabe S
Eur J Pharmacol; 1993 Jul; 238(1):117-20. PubMed ID: 8405074
[TBL] [Abstract][Full Text] [Related]
28. Working memory failure by stimulation of hippocampal adenosine A1 receptors in rats.
Ohno M; Watanabe S
Neuroreport; 1996 Nov; 7(18):3013-6. PubMed ID: 9116230
[TBL] [Abstract][Full Text] [Related]
29. Cerebral cortical muscarinic cholinergic and N-methyl-D-aspartate receptors mediate increase in cortical blood flow elicited by chemical stimulation of periaqueductal gray matter.
Nakai M; Maeda M
Neuroscience; 2000; 98(3):449-57. PubMed ID: 10869839
[TBL] [Abstract][Full Text] [Related]
30. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate.
Sun X; Larson AA
Neuroscience; 1993 Jun; 54(3):773-9. PubMed ID: 8101361
[TBL] [Abstract][Full Text] [Related]
31. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist.
Willetts J; Clissold DB; Hartman TL; Brandsgaard RR; Hamilton GS; Ferkany JW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1055-62. PubMed ID: 8099615
[TBL] [Abstract][Full Text] [Related]
32. Contribution of the basolateral amygdala NMDA and muscarinic receptors in rat's memory retrieval.
Nazarinia E; Rezayof A; Sardari M; Yazdanbakhsh N
Neurobiol Learn Mem; 2017 Mar; 139():28-36. PubMed ID: 27993648
[TBL] [Abstract][Full Text] [Related]
33. Working memory deficits induced by intrahippocampal administration of 8-OH-DPAT, a 5-HT1A receptor agonist, in the rat.
Ohno M; Yamamoto T; Watanabe S
Eur J Pharmacol; 1993 Mar; 234(1):29-34. PubMed ID: 8472759
[TBL] [Abstract][Full Text] [Related]
34. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
Lehmann J; Hutchison AJ; McPherson SE; Mondadori C; Schmutz M; Sinton CM; Tsai C; Murphy DE; Steel DJ; Williams M
J Pharmacol Exp Ther; 1988 Jul; 246(1):65-75. PubMed ID: 2899170
[TBL] [Abstract][Full Text] [Related]
35. Concurrent blockade of beta-adrenergic and muscarinic receptors disrupts working memory but not reference memory in rats.
Kobayashi M; Ohno M; Yamamoto T; Watanabe S
Physiol Behav; 1995 Aug; 58(2):307-14. PubMed ID: 7568434
[TBL] [Abstract][Full Text] [Related]
36. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors.
Carli M; Silva S; Balducci C; Samanin R
Neuropharmacology; 1999 Aug; 38(8):1165-73. PubMed ID: 10462129
[TBL] [Abstract][Full Text] [Related]
37. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats.
Wang P; Barks JD; Silverstein FS
Neuroscience; 1999 Jan; 88(2):585-97. PubMed ID: 10197777
[TBL] [Abstract][Full Text] [Related]
38. Perirhinal cortex muscarinic receptor blockade impairs taste recognition memory formation.
Gutiérrez R; De la Cruz V; Rodriguez-Ortiz CJ; Bermudez-Rattoni F
Learn Mem; 2004; 11(1):95-101. PubMed ID: 14747522
[TBL] [Abstract][Full Text] [Related]
39. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
Swan JH; Meldrum BS
J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
[TBL] [Abstract][Full Text] [Related]
40. Involvement of cholinergic and glutamatergic functions in working memory impairment induced by interleukin-1beta in rats.
Matsumoto Y; Yoshida M; Watanabe S; Yamamoto T
Eur J Pharmacol; 2001 Nov; 430(2-3):283-8. PubMed ID: 11711044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
